Inventor · disambiguated record
John D. Schreier
Also filed as: SCHREIER JOHN · SCHREIER JOHN D
21 granted patents·5 pending applications·274 citations·filing 2005–2023
95Inventor score
Files withMERCK SHARP & DOHME9COLEMAN PAUL J7BRESLIN MICHAEL J5MERCK SHARP & DOHME LLC2BERGMAN JEFFREY M1
Top patents by PatentIndex Score
26 records- 0196US8710076B22,5-disubstituted piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2009·Granted Apr 29, 2014·38 cites·7 claims
- 0296US8242121B2Pyridyl piperidine orexin receptor antagonistsCOLEMAN PAUL J·Filed 2008·Granted Aug 14, 2012·38 cites·9 claims
- 0393US8357709B22,4-disubstituted pyrrolidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 22, 2013·26 cites·20 claims
- 0492US8669272B22,5-disubstituted piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2009·Granted Mar 11, 2014·27 cites·11 claims
- 0592US8357700B22,3-disubstituted piperidine orexin receptor antagonistsMERCK SHARP & DOHME·Filed 2009·Granted Jan 22, 2013·34 cites·20 claims
- 0691US8623863B2Disubstituted azepan orexin receptor antagonistsCOLEMAN PAUL J·Filed 2009·Granted Jan 7, 2014·23 cites·19 claims
- 0790US8466281B22,5-disubstituted morpholine orexin receptor antagonistsCOLEMAN PAUL J·Filed 2009·Granted Jun 18, 2013·23 cites·11 claims
- 0889US8703770B2Pyridazine carboxamide orexin receptor antagonistsCOLEMAN PAUL J·Filed 2009·Granted Apr 22, 2014·9 cites·14 claims
- 0989US8618102B2Bridged diazepan orexin receptor antagonistsCOLEMAN PAUL J·Filed 2007·Granted Dec 31, 2013·19 cites·12 claims
- 1088US8399494B22,5-disubstituted phenyl carboxamide orexin receptor antagonistsBERGMAN JEFFREY M·Filed 2009·Granted Mar 19, 2013·17 cites·15 claims
- 1183US8569311B2Pyridyl piperidine orexin receptor antagonistsBRESLIN MICHAEL J·Filed 2012·Granted Oct 29, 2013·6 cites·15 claims
- 1281US9643982B2Fused tricyclic heterocyclic compounds as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 9, 2017·3 cites·14 claims
- 1378US10450335B2Antiviral oxime phosphoramide compoundsMERCK SHARP & DOHME·Filed 2016·Granted Oct 22, 2019·3 cites·26 claims
- 1476US10745428B2Antiviral phosphodiamide prodrugs of tenofovirMERCK SHARP & DOHME·Filed 2016·Granted Aug 18, 2020·1 cites·4 claims
- 1571US8957077B2Pyrazolopyrimidine PDE 10 inhibitorsCOX CHRISTOPHER D·Filed 2011·Granted Feb 17, 2015·2 cites·14 claims
- 1671US8691827B2Amino tetrahydro-pyridopyrimidine PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2010·Granted Apr 8, 2014·2 cites·11 claims
- 1771US8492392B2Alkoxy tetrahydro-pyridopyrimidine PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2010·Granted Jul 23, 2013·2 cites·13 claims
- 1869US10221186B2Spirocyclic heterocyclic compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Mar 5, 2019·1 cites·13 claims
- 1960US2025230161A1Polycyclic cap-dependent endonuclease inhibitors for treating or preventing influenzaMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2059US2025223259A1Protease inhibitors for treating or preventing coronavirus infectionMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2150US2009105318A1Amidoethylthioether Orexin Receptor AntagonistsCOLEMAN PAUL J·Filed 2007·Application pending·0 cites
- 2250US2015218164A1Substituted naphthyridinedione derivatives as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2345US11123355B2Antiviral benzyl-amine phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Granted Sep 21, 2021·0 cites·20 claims
- 2444US2008262046A1Amidopropoxyphenyl Orexin Receptor AntagonistsCOLEMAN PAUL J·Filed 2006·Application pending·0 cites
- 2543US7618971B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2005·Granted Nov 17, 2009·0 cites·8 claims
- 2640US10736908B2Antiviral aryl-amide phosphodiamide compoundsMERCK SHARP & DOHME·Filed 2017·Granted Aug 11, 2020·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when John D. Schreier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →